Search
Search Results
##search.searchResults.foundPlural##
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1493PDF: 926HTML: 215 -
PERPHERAL BLOOD CELL MITOCHONDRIAL DYSFUNCTION IN MYELODYSPLASTIC SYNDROMECAN BE IMPROVED BY A COMBINATION OF COENZYME Q10 AND CARNITINE Blood cell mitochondrial dysfunction in myelodysplastic syndrome
1065PDF: 753HTML: 285 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13232PDF: 955HTML: 7280 -
BACK TO THE “GOLD STANDARD”: HOW PRECISE IS HEMATOCRIT DETECTION TODAY? Novel ImageJ-based approach for the precise hematocrit measurement
1980PDF: 814HTML: 459 -
-
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1259PDF: 592HTML: 220 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4610PDF: 1305HTML: 1901Untitled: 178Untitled: 174 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1355PDF: 875HTML: 1797 -
Osteolytic bone lesions – A rare presentation of AML M6.
1957PDF: 1085HTML: 7910Untitled: 200 -
HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION
3104PDF: 1104HTML: 1743 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1539PDF: 766HTML: 1292 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3654PDF: 1229HTML: 3874Untitled: 204Untitled: 254 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2035PDF: 597Suppl. Files: 280HTML: 158 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1932PDF: 704HTML: 675Table1: patient's characteristics: 152Table 2: profile of each patient: 176 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3294PDF: 714HTML: 704Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 177Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 180Table : Distribution of the sites of bleeding and their causes: 174 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7862PDF: 4071HTML: 7331 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2569PDF: 1599HTML: 2346Table1: 187 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3342PDF: 1284HTML: 1854Fig.1: 195Fig. 2: 198 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
933PDF: 1199HTML: 99 -
-
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2188PDF: 933HTML: 6774Figure 1: 166 -
PLASMODIUM VIVAX INFECTIONS IN DUFFY-NEGATIVE INDIVIDUALS: A PARADIGM SHIFT IN INDIAN MALARIA EPIDEMIOLOGY Duffy negative malaria in India
1151PDF: 792HTML: 67 -
IS HEMOGLOBIN E GENE WIDELY SPREAD IN THE STATE OF MADHYA PRADESH IN CENTRAL INDIA? EVIDENCE FROM FIVE TYPICAL FAMILIES
1354PDF: 861HTML: 7929Untitled: 196 -
-
A strange case of Malaria in a Nigerian native boy.
2406PDF: 854HTML: 1296 -
MANAGEMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN THE ELDERLY
2729PDF: 1110HTML: 3272 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3724PDF: 1640HTML: 11548Figures Haase: 191 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1204PDF: 751HTML: 304







